HealthCor Management’s Research Alliance Corp. II Class A Common Stock RACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,324,800
Closed -$12.9M 79
2022
Q1
$12.9M Hold
1,324,800
0.86% 34
2021
Q4
$12.9M Hold
1,324,800
0.7% 40
2021
Q3
$13M Hold
1,324,800
0.56% 39
2021
Q2
$13.4M Buy
1,324,800
+324,800
+32% +$3.42M 0.54% 43
2021
Q1
$10.3M Buy
+1,000,000
New +$10.2M 0.36% 55

Other funds holding RACB

HealthCor Management's RACB Position: Q2 2022 in Review

HealthCor Management sold out of Research Alliance Corp. II Class A Common Stock (RACB) in Q2 2022, closing a stake of 1,324,800 shares — an estimated $12.9M sold.

HealthCor Management first reported a position in RACB in Q1 2021 and held it in 5 quarters. The position peaked at $13.4M in Q2 2021. 39 funds tracked by Wall St. Rank hold RACB as of Q2 2022.

  • HealthCor Management reported no remaining Research Alliance Corp. II Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • HealthCor Management sold 1,324,800 Research Alliance Corp. II Class A Common Stock shares in Q2 2022, an estimated $12.9M.
  • HealthCor Management first reported a position in Research Alliance Corp. II Class A Common Stock in Q1 2021 and held it in 5 quarters.
  • HealthCor Management's Research Alliance Corp. II Class A Common Stock position peaked at $13.4M in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Research Alliance Corp. II Class A Common Stock as of Q2 2022.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.